Skip to main content
Figure 2 | Vascular Cell

Figure 2

From: Limitations of the dorsal skinfold window chamber model in evaluating anti-angiogenic therapy during early phase of angiogenesis

Figure 2

VEGF inhibition in Caki-2 cell induced angiogenesis. Mice bearing window chambers with Caki-2 tumors were treated with VEGF inhibitor (Sunitinib). (A) Tumor volume and (B) tumor microvascular response to Sunitinib was evaluated compared to control. Median + 90/10 percentile; control (n = 8), Sunitinib (n = 7) (combination of two independent experiments). **, p < 0.01, Mann–Whitney U-Test.

Back to article page

Vascular Cell

ISSN: 2045-824X

Contact us